Sun Yat-sen University: Kidney Diseases trials

The registry lists 13 Kidney Diseases studies with Sun Yat-sen University as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 2 3Phase 3 4Phase 4 1No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Nanshan Elderly Cohort StudyRecruitingNCT03569735
• Tobacco Exposure and Influencing Factors of Smoking Cessation Among Chronic Kidney Disease PatientsCompletedNCT06303089
• Artificial Intelligence System for the Detection and Prediction of Kidney Diseases Using Ocular InformationStatus unknownNCT05223712
• Guangzhou Nutrition and Health Study (GNHS)Active, not recruitingNCT03179657
• Validity and Security of Reh-acteoside Therapy for Patients of IgA NephropathyStatus unknownNCT02662283Phase 2/3
• Aging Biomakers and ConTrast Induced Nephropathy (ACTIN) TrialCompletedNCT02650336
• Effect of Tonsillectomy on Longterm Renal Outcome of IgA NephropathySuspendedNCT02471599Not applicable
• A Controlled Study of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous NephropathyStatus unknownNCT02173106Phase 2
• A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes.Status unknownNCT02160132Phase 2
• Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic PatientsStatus unknownNCT01316068Phase 4
• Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)CompletedNCT00657059Phase 3
• Prospective, Multicenter Study of the Efficacy and Tolerance of Tacrolimus on Refractory Nephrotic Syndrome (RNS)CompletedNCT00615667Phase 3
• Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus NephritisCompletedNCT00615173Phase 3